Hal V. Barron

American biotechnologist (born 1962)

Hal V. Barron (born 1962) is an American clinician-scientist and drug developer who served as president of research and development at GlaxoSmithKline from March 2018 until 2022, when he resigned in order to join the cellular reprogramming venture Altos Labs in August of that year. Prior to this he served as president of research and development at Calico.2

From Wikipedia’s article on Hal V. Barron (this version), CC BY-SA 4.0.

Born 1962.1

Companies

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3